Ignyta Announces FDA Clearance of IND for RXDX-107

By: via Benzinga
Ignyta, Inc. (Nasdaq: RXDX) announced today that the U.S. Food and Drug Administration (FDA) has cleared the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.